The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
New robotic microtomy solution targets efficiency and scalability in laboratory tissue processing...
In a study published in Cell Reports in January 2025, titled Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma...
The platform’s creation is rooted in nearly a decade of deep collaboration by a cross-disciplinary team...
Strategic collaboration combines global MedTech development capabilities with specialised ophthalmic expertise to streamline innovation...
New clinical data and regulatory progress highlight growing adoption of pulsed field ablation technologies for complex arrhythmias...
Late-breaking data demonstrate strong durability and procedural efficiency, reinforcing potential of nanosecond pulsed field ablation in atrial fibrillation treatment...
FULCRUM-VT trial demonstrates strong safety and effectiveness outcomes, supporting potential advancement of ultra-low temperature ablation for complex arrhythmias...
Focus on real-time data insights and connected monitoring underscores shift toward precision cardiac care and improved clinical decision-making...
This study provided an imaging based assessment of the closure site and demonstrated encouraging early vascular findings in a high-risk, fully anticoagulated population, offering further insight into vascular healing following VASCADE MVP XL deployment...
